Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
Shareholders that lost money on AstraZeneca PLC(AZN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
07:25am, Thursday, 20'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 20, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
FINAL AZN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AstraZeneca PLC Investors to Join the Class Action Lawsuit
07:00am, Thursday, 20'th Feb 2025
NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against As
FibroGen sells China unit to AstraZeneca in deal worth $160 million
06:40am, Thursday, 20'th Feb 2025
FibroGen said on Thursday that it has sold its China unit to AstraZeneca for about $160 million.
NEW YORK , Feb. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class peri
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
Shareholders that Lost Money on AstraZeneca PLC (AZN) Should Contact Levi & Korsinsky about Pending Class Action - AZN
06:45pm, Wednesday, 19'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, bo
AstraZeneca Post 2024 Earnings: Unwanted Headwinds Warrant Downgrade To Hold
01:00pm, Wednesday, 19'th Feb 2025
AstraZeneca PLC beat Q4 and full-year 2024 earnings estimates, with significant revenue and EPS growth, and forecasts further growth in 2025 despite China-related setbacks. The company faces challenge
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming February 21, 2025 deadline to participate as a lead plaintiff in the securities fraud class action laws
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
11:23am, Wednesday, 19'th Feb 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In AstraZenecaTo Contact Him Directly To Discuss Their Options
What's a Good Price for AstraZeneca Stock?
11:12am, Wednesday, 19'th Feb 2025
Healthcare companies are interesting because they are not highly correlated with macroeconomic factors.
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against AstraZeneca PLC
11:00am, Wednesday, 19'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 19, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit - AZN
10:57am, Wednesday, 19'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Such investors
